[KLK] YoY TTM Result on 31-Dec-2018 [#1]

Announcement Date
18-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2019
Quarter
31-Dec-2018 [#1]
Profit Trend
QoQ- -9.25%
YoY- -29.16%
View:
Show?
TTM Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 22,444,871 15,818,341 15,526,133 17,293,121 20,700,428 17,664,158 14,873,299 7.09%
PBT 3,437,645 1,419,853 747,306 1,012,257 1,419,298 1,273,602 1,751,352 11.88%
Tax -715,747 -346,110 -177,171 -279,096 -385,956 -44,630 -264,414 18.03%
NP 2,721,898 1,073,743 570,135 733,161 1,033,342 1,228,972 1,486,938 10.59%
-
NP to SH 2,499,500 962,813 533,788 683,617 965,081 1,157,657 1,450,921 9.47%
-
Tax Rate 20.82% 24.38% 23.71% 27.57% 27.19% 3.50% 15.10% -
Total Cost 19,722,973 14,744,598 14,955,998 16,559,960 19,667,086 16,435,186 13,386,361 6.66%
-
Net Worth 12,384,921 10,903,420 10,213,021 10,766,802 11,576,176 11,160,839 10,276,918 3.15%
Dividend
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div 215,705 160,569 159,744 159,744 532,482 532,482 479,234 -12.44%
Div Payout % 8.63% 16.68% 29.93% 23.37% 55.17% 46.00% 33.03% -
Equity
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 12,384,921 10,903,420 10,213,021 10,766,802 11,576,176 11,160,839 10,276,918 3.15%
NOSH 1,081,017 1,081,017 1,064,965 1,064,965 1,064,965 1,064,965 1,064,965 0.24%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 12.13% 6.79% 3.67% 4.24% 4.99% 6.96% 10.00% -
ROE 20.18% 8.83% 5.23% 6.35% 8.34% 10.37% 14.12% -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 2,082.30 1,466.73 1,457.90 1,623.82 1,943.76 1,658.66 1,396.60 6.87%
EPS 231.89 89.28 50.12 64.19 90.62 108.70 136.24 9.25%
DPS 20.00 15.00 15.00 15.00 50.00 50.00 45.00 -12.63%
NAPS 11.49 10.11 9.59 10.11 10.87 10.48 9.65 2.94%
Adjusted Per Share Value based on latest NOSH - 1,064,965
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 2,042.32 1,439.36 1,412.77 1,573.55 1,883.59 1,607.31 1,353.36 7.09%
EPS 227.44 87.61 48.57 62.20 87.82 105.34 132.02 9.48%
DPS 19.63 14.61 14.54 14.54 48.45 48.45 43.61 -12.44%
NAPS 11.2694 9.9213 9.2931 9.797 10.5335 10.1556 9.3513 3.15%
Price Multiplier on Financial Quarter End Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 21.78 23.68 24.80 24.72 25.00 24.00 22.88 -
P/RPS 1.05 1.61 1.70 1.52 1.29 1.45 1.64 -7.15%
P/EPS 9.39 26.52 49.48 38.51 27.59 22.08 16.79 -9.22%
EY 10.65 3.77 2.02 2.60 3.62 4.53 5.95 10.17%
DY 0.92 0.63 0.60 0.61 2.00 2.08 1.97 -11.90%
P/NAPS 1.90 2.34 2.59 2.45 2.30 2.29 2.37 -3.61%
Price Multiplier on Announcement Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 16/02/22 17/02/21 17/02/20 18/02/19 12/02/18 14/02/17 17/02/16 -
Price 25.60 22.76 23.74 24.74 25.24 25.10 23.66 -
P/RPS 1.23 1.55 1.63 1.52 1.30 1.51 1.69 -5.15%
P/EPS 11.04 25.49 47.36 38.54 27.85 23.09 17.37 -7.26%
EY 9.06 3.92 2.11 2.59 3.59 4.33 5.76 7.83%
DY 0.78 0.66 0.63 0.61 1.98 1.99 1.90 -13.77%
P/NAPS 2.23 2.25 2.48 2.45 2.32 2.40 2.45 -1.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment